Personalized Medicine

NAPLES, Florida — In this video, Anita Afzali, MD, MPH, FACG, discusses key takeaways from her presentation on precision therapy in IBD at the 2022 ACG/FGS Spring Symposium.

Charu Aggarwal, MD, MPH, spoke with Healio about a presentation she gave at this year’s Chemotherapy Foundation Symposium.

Tailored Parkinson’s disease gait impairment compensation strategies may help patients, according to results of a survey study published in Neurology.

In this episode, Lance Baldo, MD, discusses the use of MRD testing, T-cell receptor profiling, and how lessons from the COVID-19 pandemic will help shape the future of cancer vaccines.

A new phase 2 clinical trial of multiple therapies to treat patients with severe asthma, specifically focusing on personalized therapies based on genetics, family history, lifestyle and environmental factors, is currently underway.

In this episode, Julie Rubinstein, MBA, discusses her journey into the cancer space, the importance of personalized medicine and how her father’s cancer diagnosis played a role in her career.

Healio spoke with Jonathan M. Gerber, MD, of the Center for Cancer Excellence at the University of Massachusetts Medical School and UMass Memorial Health Care System, and HemOnc Today Editorial Board member, about breakthroughs in therapy that he hopes to see in the future.

A personalized genomic vaccine administered after standard-of-care adjuvant therapy appeared safe and induced immunogenicity among patients with different cancers at a high risk for recurrence, according to results of a phase 1 trial.

In this video, Roy S. Herbst, MD, PhD, associate cancer center director for translational research at Yale Cancer Center, provided a quick rundown of presentations from the Chemotherapy Foundation Symposium that focused on targeted therapy.

While the rheumatology community often finds itself behind other specialties in head-to-head trials of drugs or drug classes, new data may help clinicians in decision-making, according to a presenter at ACR 2020.